Please use this identifier to cite or link to this item:
Author(s): Coelho, R
Ricardo, S
Amaral, AL
Huang, YL
Nunes, M
Neves, JP
Mendes, N
López, MN
Bartosch, C
Ferreira, V
Portugal, R
Lopes, JM
Almeida, R
Heinzelmann-Schwarz, V
Jacob, F
David, L
Title: Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation
Publisher: Nature Publishing Group
Issue Date: 2020
Abstract: Peritoneal dissemination is a particular form of metastasis typically observed in ovarian cancer and the major cause for poor patient’s outcome. Identification of the molecular players involved in ovarian cancer dissemination can offer an approach to develop treatment strategies to improve clinical prognosis. Here, we identified mesothelin (MSLN) as a crucial protein in the multistep process of peritoneal dissemination of ovarian cancer. We demonstrated that MSLN is overexpressed in primary and matched peritoneal metastasis of high-grade serous carcinomas (HGSC). Using several genetically engineered ovarian cancer cell lines, resulting in loss or gain of function, we found that MSLN increased cell survival in suspension and invasion of tumor cells through the mesothelial cell layer in vitro. Intraperitoneal xenografts established with MSLNhigh ovarian cancer cell lines showed enhanced tumor burden and spread within the peritoneal cavity. These findings provide strong evidences that MSLN is a key player in ovarian cancer progression by triggering peritoneal dissemination and provide support for further clinical investigation of MSLN as a therapeutic target in HGSC.
Source: Oncogenesis, vol.9(6):61
Document Type: Artigo em Revista Científica Internacional
Rights: openAccess
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.1038-s41389-020-00246-2.pdf5.98 MBAdobe PDFThumbnail

This item is licensed under a Creative Commons License Creative Commons